Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Anesthesia for the obstetric patient with multiple sclerosis.
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
The role of IL-17 in CNS diseases.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
The prevalence of urinary catheterization in women and men with multiple sclerosis.
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.
Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.
Cover Images.
Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis.
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?
Not Lost in Translation: Emerging Clinical Importance of the G Protein-Coupled Estrogen Receptor GPER.
Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity.
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Pages
« first
‹ previous
…
418
419
420
421
422
423
424
425
426
…
next ›
last »